US EditionPublished • loading... • Updated
Canadian health officials warn against counterfeit versions of Ozempic, Mounjaro
Health Canada warns counterfeit GLP-1 drugs sold nationwide may contain dangerous ingredients and pose serious health risks, urging purchases only from licensed pharmacies.
- On Wednesday, Health Canada issued a public advisory warning people not to buy or use unauthorized GLP-1 drugs including semaglutide, the active ingredient in Ozempic and Wegovy, saying do not buy or use unauthorized products.
- Rising demand for weight‑loss GLP-1s has led to growing interest in these products, prompting people to seek unauthorized options sold by retailers and online sellers in Canada.
- Unauthorized products pose multiple safety hazards, including incorrect ingredients and contamination, while websites and social media advertisers misuse Health Canada logos to mislead consumers, Health Canada said.
- Health Canada is coordinating with the Canada Border Services Agency to block shipments, actively monitoring the market, seizing products, and advising purchases only from licensed pharmacies with an eight‑digit DIN.
- To protect patients, the regulator urges reporting of suspected counterfeits and side effects, noting genuine GLP-1 therapies list serious risks; Health Canada advises people who have used unauthorized GLP-1 products to consult health‑care professionals and report concerns to its reporting system.
Insights by Ground AI
9 Articles
9 Articles
Beware 'fauxzempic': Health Canada warns people to watch for fake GLP
Health Canada is warning people not to buy or use fake or unauthorized versions of GLP-1 drugs such as semaglutide, the active ingredient in Ozempic and Wegovy. The health agency says it has found retailers in Canada selling unauthorized GLP-1 products — sometimes referred to as "fauxzempic" — both in stores and online.
·Canada
Read Full Article
The Hamilton Spectator+4 Reposted by 4 other sources
Growing popularity of GLP-1 drugs, such as Ozempic, prompts warning from Health Canada
The popularity of GLP-1 drugs in Canada has prompted a warning from Health Canada about the risks of unauthorized and counterfeit drugs.
·Hamilton, Canada
Read Full Article
Coverage Details
Total News Sources9
Leaning Left5Leaning Right0Center2Last UpdatedBias Distribution71% Left
Bias Distribution
- 71% of the sources lean Left
71% Left
L 71%
C 29%
Factuality
To view factuality data please Upgrade to Premium
